Direct immunofluorescence for autoimmune bullous diseases - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses a recent change to the direct immunofluorescence assay, specifically the addition of the IgG4 conjugate.
Highlighting MML Regional Service Representatives - Insights
Our Mayo Medical Laboratory regional service representatives provide outstanding support to our clients and have the opportunity to share the Mayo Clinic mission and expertise with laboratories around the world. To gain a good understanding...
What's New in Health Care Reform: Jan. 9 - Insights
Top highlights include: new research shows sugar substitutes are not healthier than real sugar, how light therapy helps Minnesotans during winter, what you must know about Parkinson's disease, new law requires hospitals post prices online,...
Lessons from Leaders: Who Let the DOGs Out? - Insights
Andy Cousin, FACHE, Director of Product Management and Marketing, interviews Amy Clayton, M.D., Division Chair of Anatomic Pathology at Mayo Clinic, about "disease-oriented groups," which are multidisciplinary teams formed to establish a...
Lab discoveries fuel updates for autoimmune movement disorders test - Insights
Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...
Transforming clinical practice and changing outcomes for brain tumor patients - Insights
The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...
Phage immunoprecipitation sequencing identifies previously unknown disease biomarkers - Insights
In Mayo Clinic’s Advanced Diagnostics Laboratory, there are dozens of projects underway at once to develop new technologies, discover novel findings, validate new tests, and support physicians in providing advanced patient care. For...
Relentless innovation - Insights
Inspired by Mayo Clinic’s history of breaking down barriers to change medicine, we are constantly reimagining what’s possible in diagnostics.
Controlled substance monitoring - Insights
The Clinical and Forensic Toxicology Laboratory at Mayo Clinic offers the industry’s most comprehensive evidence-based urine drug testing menu to evaluate for the presence of controlled substances.
Clinic’s commitment to meeting the needs of every patient, from the smallest to the tallest, is central to our approach to pediatric gastroenterology testing. Developed in collaboration with Mayo Clinic’s top-ranked GI experts, our...